Health Technology Entrepreneurship Commercialization Consultants

Technology Development

Contents

2

3

4

About Health TECC

Health TECC’s Clients

The Application Process

Health TECC advises early-stage healthcare

focused companiesThe Healthcare Consulting and Entrepreneurship Program (HCEP),

now known as Health TECC, was established at Boston University in 1996. Health TECC’s mission is to support entrepreneurship in health

care, focusing on businesses in the incubation and start-up phase. Health TECC specializes in pharmaceuticals, biotechnology, medical

device, and other healthcare technology including health IT.

The combination of business, engineering, scientific and medical

expertise represented by the grad student members of the group is at the core

of what allows the group to provide outstanding and

timely help.

Michael Koeris, Novophage CEO

History

TECC was founded in 2011 when consultants from the HCEP became affiliated with the Office of Technology and Development (OTD) and merged with IPconnectED, a student group focused on intellectual property. Health TECC is now the exclusive student group affiliated with OTD in providing healthcare-focused consulting services.

The Health TECC experience

Health TECC members are pro-bono consultants specializing in pharmaceuticals, biotechnology, and medical device. Health TECC collaborates with entrepreneurs affiliated with the Office of Technology Development, the Photonics Center, BioSquare, the Fraunhofer USA Center, and the Entrepreneurial Management Institute.

Members

Health TECC members are an interdisciplinary group of graduate students composed of MBA, PhD, and medical students. This year, Health TECC aims to expand its membership to law students.

Services:

Market access

Reimbursement strategy

Health economics

Opportunity assessment

Regulatory considerations

Intellectual property and patent law

Health TECC2

Employers of Past and Current Health

TECC Members:

BearingPoint

Biogen

Biotronic

Boston MedTech Advisors Bridgehead

International Bristol-Myers Squibb’s

biotechnology technical services

division

Campbell Alliance

Cadence Capital

Decision Resources

Electronic Systems Center and Space

and Missile Command Flagship

Ventures

Genzyme

Johns Hopkins Institute for Cell

Engineering

Leerink Swann

McKinsey

The MITRE Corporation

National Cancer Institute Novophage

Palomar Medical Technologies

PricewaterhouseCoopers

PRTM Management Consultants

Sentient Medical Systems

Past Clients

Novophage

Novophage provides biological solutions for industrial biofilms and has recently received $5.75 million in funding. Michael Koeris, the CEO, who served as an HCEP consultant during his PhD candidacy at Boston University, requested HCEP’s consulting services. As advisors, HCEP:

• analyzed potential regulatory pathways for approval of a novel phage-based antimicrobial;

Health TECC3

• appraised the client of the regulatory environment; and

• identified potential collaboratorsfor Novophage.

Good Start Genetics

Good Start Genetics provides the next generation in technology for genetic screening. HCEP contributions included:

• comparing capital financing options for large equipment purchases through financial modeling;

• identifying key opinion leaders; and• formulating recommendations that

suited the business and cash flow needs of the client.

Entra Pharmaceuticals

Entra Pharmaceuticals is a medical device company that focuses on innovative drug delivery technology. HCEP consultants:

• investigated four therapeutic areas and identified a market access strategy; and

• provided a competitive analysis of the medical device industry.

Entra Pharmaceuticals implemented many of HCEP’s recommendations, including a strategy for new productdevelopment.

Companion Diagnostics

A client with a start-up specializing in companion diagnostics approached HealthTECC, who:

• conducted primary research with prominent pathologists and oncologists to facilitate market adoption;

• performed a thorough analysis of the regulatory pathway for medical diagnostics;

• developed economic models to compare potential business structures; and

• evaluated the advantages and disadvantages in bringing the product to market as a companion diagnostic.

Medical Device

A client who developed a product for the early detection of autism utilized HealthTECC to:

• conduct primary research to evaluate factors surrounding market adoption from customer and consumer perspectives; qualified the current reimbursement landscape; quantified the value-added, which was used for value-based pricing; and

• examined HIPAA issues the client would likely encounter due to the use of HIT.

Areas of Expertise:

Anti-Infectives Child Development

Companion Diagnostics Genetic Screening

Neurology Oncology

Personalized Medicine

Health TECC will accept applications from:

The School of Management The College of Engineering The Law SchoolBoston Medical Center

What To Expect

• Confirmation upon receipt of application• Application deadline: Wednesday October

16, 2013• Notification of interview selection by:

Sunday October 20, 2013• Interview date: Tuesday October 22, 2013• New consultants announced by: Sunday

October 27, 2013• New member introduction at first general

meeting: Wednesday October 30, 2013

Health TECC4

Managing Directors

Cory Peterson, MBA CandidateSalwa Masud, MS Candidate, BME

http://www.bu.edu/otd/education/tecc-student-consultants/

Facebook: Technology Entrepreneurship and Commercialization Consultants (TECC)

Email inquiries:HealthTECC.BU@gmail.com